[HTML][HTML] Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome

F Lin, TE Ichim, S Pingle, LD Jones… - World journal of stem …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), a pandemic disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV2), is growing at an exponential rate …

[HTML][HTML] Mesenchymal stem cells (MSCs) as a potential therapeutic strategy in COVID-19 patients: literature research

A Coelho, RD Alvites, MV Branquinho… - Frontiers in cell and …, 2020 - frontiersin.org
In 2019, an outbreak of an unknown coronavirus–SARS-CoV-2–responsible for COVID-19
disease, was first reported in China, and evolved into a pandemic of huge dimensions and …

[HTML][HTML] The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm

M Kavianpour, M Saleh, J Verdi - Stem Cell Research & Therapy, 2020 - Springer
The outbreak of coronavirus disease 2019 (COVID-19) pandemic is quickly spreading all
over the world. This virus, which is called SARS-CoV-2, has infected tens of thousands of …

Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment

SS Raza, MA Khan - Cytotherapy, 2022 - Elsevier
Currently, treating coronavirus disease 2019 (COVID-19) patients, particularly those afflicted
with severe pneumonia, is challenging, as no effective pharmacotherapy for severe acute …

[HTML][HTML] Stem cells therapy as a possible therapeutic option in treating COVID-19 patients

D Esquivel, R Mishra, P Soni, R Seetharaman… - Stem cell reviews and …, 2021 - Springer
An unfortunate emergence of a new virus SARS-CoV-2, causing a disease known as COVID-
19, has spread all around the globe and has caused a pandemic. It primarily affects the …

Mesenchymal Stem Cells and COVID‐19: Cure, Prevention, and Vaccination

M Afarid, F Sanie-Jahromi - Stem cells international, 2021 - Wiley Online Library
COVID‐19 disease has been a global health problem since late 2019. There are many
concerns about the rapid spread of this disease, and yet, there is no approved treatment for …

[HTML][HTML] Mesenchymal stem cells as a potential therapy for COVID-19

S Liu, D Peng, H Qiu, K Yang, Z Fu, L Zou - Stem cell research & therapy, 2020 - Springer
The outbreak of 2019 novel coronavirus disease (COVID-19) worldwide is becoming rapidly
a major concern. The number of severe cases has increased dramatically worldwide, while …

Feasibility of mesenchymal stem cell therapy for COVID-19: a mini review

J Li, X Wang, N Li, Y Jiang, H Huang… - Current Gene …, 2020 - ingentaconnect.com
Patients infected with SARS-CoV-2 carry the coronavirus disease 2019 (COVID-19) which
involves multiple systems and organs with acute respiratory distress syndrome (ARDS) as …

[HTML][HTML] Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection

P Mallis, E Michalopoulos… - World Journal of Stem …, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2 and the related coronavirus disease-19
(COVID-19) is a worldwide emerging situation, which was initially reported in December …

[HTML][HTML] Mesenchymal stem cell therapy for severe COVID-19

L Shi, L Wang, R Xu, C Zhang, Y Xie, K Liu… - Signal transduction and …, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health …